Infusion Therapy for Ulcerative Colitis in Glen Burnie, MD

At Jean Walter Infusion Center, Dr. Nasser Nasseri, MD, has been providing high-quality infusion therapy for ulcerative colitis for many years. We understand that the effectiveness of infusion therapy can differ significantly depending on factors such as disease severity, overall health, and how a person responds to treatment.

Most of our patients begin to see some improvement in their symptoms within 2-6 weeks of starting infusion therapy. This initial response may include reduced inflammation and improved bowel habits. Achieving a full response, which is characterized by complete remission or significant symptom control, might take a little longer, perhaps up to three months, or even several months of regular infusions at our center.

We understand that the timeline for results can greatly differ for individuals with severe ulcerative colitis who may require a longer duration of treatment to see improvement. We take into account individual variations in the immune system and disease activity, which can affect the speed and effectiveness of response. Adherence to the prescribed infusion schedule and dosage is crucial for achieving the best possible results. We emphasize the importance of keeping all scheduled appointments and following the treatment plan.

Regular follow-up appointments are crucial to monitor your progress, assess symptoms, perform physical examinations, and order necessary tests or imaging studies to evaluate your response to therapy.

While infusion therapy is not a cure for ulcerative colitis, it can substantially improve symptoms and potentially induce remission. We will guide you through the process, stressing the importance of continuing the therapy as directed because stopping prematurely could potentially result in a return of symptoms.

We understand the concern patients with ulcerative colitis may have concerning the safety of long-term infusion therapy. This treatment method involves administering medication intravenously and offers significant benefits in controlling disease activity and reducing inflammation. While infusion therapy is not always the first line of treatment, it is often employed when other treatments prove unsuccessful or if the disease is severe.

We ensure that the safety of our patients is paramount. He understands that while initial studies have demonstrated the effectiveness of infusion therapy with biologics such as Infliximab and Vedolizumab in achieving remission and reducing disease severity, there are potential risks and complications. These could include immune suppression, allergic reactions, and increased cancer risk, all of which are carefully considered before any treatment begins.

Patients undergoing long-term infusion therapy for ulcerative colitis can rest assured that regular monitoring and management will be in place. These include infection surveillance, allergy management, cancer screening, liver function monitoring, and infusion optimization. The team works closely with patients, ensuring that their health and safety are always prioritized.

Before starting any long-term treatment plan, we will have a thorough discussion with patients. We will discuss the patient’s medical history, potential risks and benefits of infusion therapy, and address any concerns that patients may have.

While infusion therapy does carry some risks, it is generally safe for the long-term treatment of ulcerative colitis. The decision to use infusion therapy will be made collaboratively with the patient, taking into account the individual’s disease severity, overall health, lifestyle, and personal preferences. While potential risks exist, they are typically manageable with careful monitoring and appropriate medical management. Regular follow-up and patient education are essential to ensuring the safety and effectiveness of this therapy over the long term.

Ulcerative colitis is an inflammatory bowel disease that targets the large intestine. A typical treatment approach for this condition is infusion therapy, where medication is administered directly into a vein to reduce inflammation and suppress the immune system.

In most cases, patients will be advised to continue with other medications while receiving infusion therapy for ulcerative colitis. Ulcerative colitis often requires a comprehensive treatment approach, and infusion therapy is just one aspect of it. Additionally, you may be on other medications to manage symptoms or treat other health conditions.

However, as the medical situation varies from one person to another, what suits one person may not be appropriate for another. Consequently, it’s vital to discuss all the medications you’re currently on with your healthcare provider, including over-the-counter drugs and supplements.

Our healthcare providers will provide an all-encompassing understanding of how your medications may interact with each other. They can closely monitor your progress and adjust your treatment plan as necessary. In certain instances, some medications might need to be adjusted or discontinued during infusion therapy to prevent potentially harmful interactions or side effects.

Inform your healthcare provider about the medications you are currently taking, including both prescription as well as over-the-counter medications, including the use of supplements or herbal remedies. Do not cease the use of any medications without first consulting your healthcare provider.

While it’s often safe and necessary to continue other medications during infusion therapy for ulcerative colitis, it’s always best to consult with your healthcare provider at Jean Walter Infusion Center.
Visit Jean Walter Infusion Center for the treatment of ulcerative colitis. For more information, contact us or book an appointment online. We are conveniently located at 203 Hospital Dr, Suite 300A, Glen Burnie, MD 21061. We serve patients from Glen Burnie MD, Pasadena MD, Edgewater MD, Jacobsville MD, Ferndale MD, Severn MD, and surrounding areas.